Advertisement

Topics

AACR: How do melanoma cells survive drug treatment long enough to acquire drug resistance?

20:00 EDT 15 Apr 2018 | AAAS

(University of Colorado Anschutz Medical Campus) 'What we find is that dabrafenib, even at high doses, does not fully turn off the MAPK pathway, thereby enabling eventual escape from drug,' says Sabrina Spencer, Ph.D.

Original Article: AACR: How do melanoma cells survive drug treatment long enough to acquire drug resistance?

NEXT ARTICLE

More From BioPortfolio on "AACR: How do melanoma cells survive drug treatment long enough to acquire drug resistance?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...